UK Association for the Cannabinoid Industry (ACI) has announced the deadline for the Novel Foods application process from its members for December 20. 

The date has been chosen to be able to submit the applications to  European Food Safety Authority (EFSA) within 6 months of the 2020, reads the announcement. The safety assessment is required by EFSA to prove that CBD manufacturers can ensure consistency in safety and quality of the end products.

Dr Sarah Gaunt from Global Regulatory Services shared that ACI was able to identify “ideal” partners “through a thorough analysis of world-class testing laboratories” with an end goal to “create a solid foundation for building a responsible and safe industry in Europe and beyond”.

The product testing will include the analysis “for cannabinoids, terpenes, pyrrolizidine alkaloids, microbiology, mycotoxins, pesticides, residual solvents, heavy metals and genotoxicity”. Also the organisation commits to working with academia in order to finalise requirements for CBD products manufacturers.

The representative of one of the ACI members from Mile High Lab Wendi Young has shared that the company has been working on the application “over the last few months” and supports initiatives that ensure compliance and boost consumer confidence in CBD industry.


On December 11, Strategic Counsel of ACI Steve Moore also shared the statement that the organisation is working on fostering “legally compliant, socially responsible and innovative CBD industry” and urges companies to sign up for the quality check program, as customers “should feel confident about the quality of the CBD products on offer in retail”.